This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of levodopa decarboxylase inhibitor
PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
6786 |
4. Check minimum number of events
Min. number of events
3
|
6786 |
5. Include endpointsNone |
6786 |
6. Filter based on genotype QC (FinnGen only) |
6057 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of levodopa decarboxylase inhibitor
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6057 | 2435 | 3622 |
| Unadjusted period prevalence (%) | 1.34 | 0.86 | 1.66 |
| Median age at first event (years) | 72.00 | 71.12 | 72.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 6192
- Matched controls
- 61920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
76.0
307.7
220
30
N04BD01
ATC
selegiline; oral
360.5
307.7
1986
81
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
63.5
307.7
250
41
N87
ICPC
Parkinsonism
332.6
307.7
2249
106
G20
ICD-10 Finland
Parkinson disease
1161.9
307.7
5139
259
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
+∞
307.7
6192
345
N04AA02
ATC
biperiden; systemic
11.3
307.7
358
333
N03AE01
ATC
clonazepam; systemic
5.6
307.7
847
1706
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
1035.1
307.7
1493
19
N04BC05
ATC
pramipexole; oral
13.5
307.7
2322
2639
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
179.4
307.7
258
15
N05AH04
ATC
quetiapine; oral
4.2
307.7
1798
5467
G04BD12
ATC
mirabegron; oral
3.3
307.7
1603
5910
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
1618.9
307.7
4943
151
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
657.6
307.7
851
15
N06DA03
ATC
rivastigmine; oral, transdermal
8.4
307.7
1421
2122
N04BX04
ATC
opicapone; oral
3161.1
307.7
311
*
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
83.0
307.7
193
24
N04BX02
ATC
entacapone; oral
+∞
307.7
502
*
193
Kela drug reimbursment
Rasagiline
1566.9
307.7
817
6
N04BD02
ATC
rasagiline; oral
1187.7
307.7
1079
11
R25.1
ICD-10 Finland
Tremor, unspecified
17.1
307.7
1219
873
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
57.6
307.7
270
49
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
48.1
307.7
810
193
N04BC09
ATC
rotigotine; transdermal
184.8
307.7
462
27
N04BB01
ATC
amantadine; oral
16.2
307.7
439
290
N04BC04
ATC
ropinirole; oral
150.8
307.7
1234
102
H02AA02
ATC
fludrocortisone; oral
16.5
307.7
297
188
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
296.8
994
2884
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
78.9
288.6
154
20
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
17.3
270.7
224
134
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
31.8
257.3
167
54
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
5.9
246.2
461
829
L28
ICPC
Limited function/disability (L)
2.5
222.0
2040
10275
R53
ICD-10 Finland
Malaise and fatigue
2.4
220.6
2150
11115
I95.1
ICD-10 Finland
Orthostatic hypotension
3.9
215.2
685
1899
G21.8
ICD-10 Finland
Other secondary parkinsonism
51.4
202.0
116
23
A28
ICPC
Limited function/disability NOS
2.4
201.6
2069
10862
C07AA05
ATC
propranolol; systemic
2.6
197.5
1387
6107
XA800
NOMESCO Finland
Neuropsychological investigation
4.9
185.8
428
923
N19
ICPC
Speech disorder
7.8
185.7
261
346
R4130
NOMESCO Finland
Speech therapy
5.3
183.8
387
772
N04BC06
ATC
cabergoline; oral
27.9
181.8
123
45
AA1AD
NOMESCO Finland
CT of head and brain
2.1
178.4
2658
16061
XF606
NOMESCO Finland
Ortostatic test
9.1
168.3
209
238
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
160.1
776
2788
G25.2
ICD-10 Finland
Other specified forms of tremor
12.8
160.1
156
125
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.0
158.1
353
740
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
155.0
2621
16365
N28
ICPC
Limited function/disability (N)
5.7
152.7
294
540
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
151.6
1980
11219
SPAT1229
SPAT
Assessment of need for aid
2.7
145.2
860
3435
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
485.7
144.0
143
*
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
57.9
142.4
80
14
G25.0
ICD-10 Finland
Essential tremor
4.3
140.1
378
922
N29
ICPC
Neurological sympt/complt other
5.3
135.5
280
548
A06AD11
ATC
lactulose; oral
2.2
133.8
1514
8056
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
6.7
128.2
206
316
SPAT1216
SPAT
Assessment of functional ability
2.1
124.7
1498
8127
G02CB01
ATC
bromocriptine; systemic
10.0
120.4
138
141
N06AX11
ATC
mirtazapine; oral
1.9
118.6
2280
14531
R5110, ,
SPAT
2.4
113.7
865
3872
N04BC02
ATC
pergolide; oral
1118.7
112.9
110
*
R1250
NOMESCO Finland
Evaluation of functional capability
4.4
112.6
290
681
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
111.0
2101
13258
D21
ICPC
Swallowing problem
5.1
110.4
237
479
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
108.2
1361
7460
G90.3
ICD-10 Finland
Multi-system degeneration
52.2
108.1
62
12
R4130, ,
SPAT
14.5
107.5
97
68
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
106.1
640
2560
N06AB10
ATC
escitalopram; oral
2.2
103.9
1079
5492
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
103.6
1384
7737
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.2
97.4
267
657
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.7
97.2
591
2370
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
2.8
96.7
521
1964
N99
ICPC
Neurological disease other
5.5
94.0
185
346
U04
ICPC
Incontinence urine
2.5
93.3
632
2669
N05BA04
ATC
oxazepam; oral
1.8
90.8
1771
11141
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
7.5
90.1
130
177
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.3
89.9
798
3796
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
88.7
85
*
S01.0
ICD-10 Finland
Open wound of scalp
2.3
88.1
737
3418
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
87.7
826
4023
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.2
87.2
373
1234
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
85.8
676
3053
A04
ICPC
Weakness/tiredness general
1.9
84.7
1206
6837
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.8
84.1
264
716
G24.9
ICD-10 Finland
Dystonia, unspecified
16.8
84.1
70
42
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
96.9
78.1
86
9
N03AX12
ATC
[U] gabapentin; oral
1.9
77.0
1116
6344
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
76.9
1234
7251
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.5
76.8
538
2301
SPAT1234
SPAT
Support of social functional capacity
2.4
72.5
530
2309
R47.1
ICD-10 Finland
Dysarthria and anarthria
5.2
70.0
145
284
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
67.9
634
3061
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
67.1
1258
7718
N30.0
ICD-10 Finland
Acute cystitis
1.8
66.7
1120
6644
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.3
65.8
259
814
R35
ICD-10 Finland
Polyuria
2.2
64.9
634
3114
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
63.8
481
2121
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
10.0
63.1
72
73
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
61.8
394
1608
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.4
61.6
232
709
Z2445
NOMESCO Finland
Psychologist
3.6
61.4
208
594
R44.1
ICD-10 Finland
Visual hallucinations
7.0
61.3
94
137
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.5
59.9
405
1699
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
593.9
59.8
59
*
F0230, G20,
ICD-10 Finland
593.9
59.8
59
*
R4110, ,
SPAT
1.9
59.4
940
5456
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
9.3
59.2
71
77
F0232, G20,
ICD-10 Finland
+∞
58.4
56
*
S72.0
ICD-10 Finland
Fracture of neck of femur
2.3
57.3
444
1980
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
22.2
57.0
42
19
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
4.8
55.5
126
267
N08
ICPC
Abnormal involuntary movements
9.3
54.8
66
72
P20
ICPC
Memory disturbance
1.7
53.8
1325
8699
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
50.3
2054
15145
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
49.1
1061
6709
G23.2
ICD-10 Finland
Multiple system atrophy, parkinsonian type [MSA-P]
168.0
47.9
50
*
R4120, ,
SPAT
4.0
47.0
135
344
W19
ICD-10 Finland
Unspecified fall
1.9
46.6
709
4045
R1420, ,
SPAT
6.2
46.6
79
128
M03BX01
ATC
baclofen; systemic
3.6
46.6
153
428
R1260
NOMESCO Finland
Evaluation of communicative skills
3.5
46.1
163
479
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
4.9
45.8
100
205
K59.0
ICD-10 Finland
Constipation
2.1
45.6
468
2333
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
45.5
324
1389
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.6
45.1
281
1133
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
3.4
44.1
160
478
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.5
43.6
287
1187
SPAT1053
SPAT
Memory test
1.6
43.5
1291
8811
N06AB04
ATC
citalopram; systemic
1.6
42.6
1201
8094
R1250, ,
SPAT
2.6
42.6
245
950
130
Kela drug reimbursment
Malignant tumour
0.3
42.3
154
4371
H50.52
ICD-10 Finland
Exophoria
5.4
42.0
83
156
N06AX21
ATC
duloxetine; oral
1.8
41.4
631
3597
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
4.1
41.1
113
279
M48.0
ICD-10 Finland
Spinal stenosis
1.7
40.9
967
6234
S06.0
ICD-10 Finland
Concussion
1.8
40.7
662
3849
N02BE01
ATC
paracetamol; systemic, rectal
1.7
39.9
5345
49022
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
39.0
1686
12439
N06AX26
ATC
vortioxetine; oral
2.2
38.6
341
1602
N03AG01
ATC
valproic acid; systemic, rectal
2.2
38.2
338
1588
AXX01
NOMESCO Finland
Memory assessment
4.4
37.8
96
223
R23
ICPC
Voice symptom/complaint
3.3
37.6
144
445
R41.0
ICD-10 Finland
Disorientation, unspecified
2.3
37.2
299
1351
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
37.0
794
4982
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.7
36.8
195
725
G04BD08
ATC
solifenacin; oral
1.9
36.7
519
2886
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.6
36.6
122
345
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
36.5
35
*
N04BC07
ATC
apomorphine; parenteral
+∞
36.5
35
*
R13
ICD-10 Finland
Dysphagia
1.9
36.3
521
2909
G04BD11
ATC
fesoterodine; oral
2.4
36.1
245
1028
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.7
36.0
804
5095
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
35.7
664
4007
J01EA01
ATC
trimethoprim; systemic
1.5
35.5
1514
11104
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
35.3
524
2956
N06AX16
ATC
venlafaxine; oral
1.8
35.1
615
3648
N02AA05
ATC
oxycodone; systemic
1.5
34.9
1405
10180
R5130, ,
SPAT
5.8
34.8
63
109
M54.5
ICD-10 Finland
Low back pain
1.4
34.8
1876
14380
R55
ICD-10 Finland
Syncope and collapse
1.6
33.9
835
5418
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
33.9
439
2370
TAB00
NOMESCO Finland
Lumbar puncture
2.4
33.8
248
1077
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.0
33.8
395
2059
R60.0
ICD-10 Finland
Localized oedema
1.6
33.6
912
6060
N86
ICPC
Multiple sclerosis
6.8
33.5
52
77
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
6.8
33.5
52
77
F06.0
ICD-10 Finland
Organic hallucinosis
8.5
33.5
43
51
N04BC01
ATC
bromocriptine; oral
50.3
33.4
40
8
R2110
NOMESCO Finland
Giving the first information
2.1
33.4
335
1653
R32
ICD-10 Finland
Unspecified urinary incontinence
2.4
33.3
229
966
D12
ICPC
Constipation
2.1
33.0
307
1472
R1430, ,
SPAT
3.4
33.0
117
345
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.4
33.0
239
1033
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.6
32.9
190
738
SPAT1301
SPAT
No procedures
1.4
32.7
1967
15339
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
6.1
32.6
56
92
N05AH02
ATC
clozapine; systemic
4.4
32.6
81
185
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
32.4
329
1631
SPAT1254
SPAT
Administration of medicine
1.5
31.8
1013
6971
AA5QN, ,
NOMESCO Finland
43.6
31.8
39
9
S70.0
ICD-10 Finland
Contusion of hip
2.1
31.3
310
1521
XKD00
NOMESCO Finland
Uroflowmetry
1.5
31.3
1321
9634
J01CA08
ATC
pivmecillinam; oral
1.4
31.1
1876
14603
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
30.6
605
3704
R42
ICD-10 Finland
Dizziness and giddiness
1.4
30.4
1547
11679
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
30.2
455
2576
H50.31
ICD-10 Finland
Intermittent exotropia
5.8
30.0
54
93
S01.8
ICD-10 Finland
Open wound of other parts of head
3.0
29.9
130
434
G24.8
ICD-10 Finland
Other dystonia
8.2
29.5
39
48
G04BD09
ATC
trospium; oral
2.4
29.4
197
822
N02BF01
ATC
gabapentin; oral
1.7
29.3
593
3652
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
29.2
2610
21602
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
28.9
362
1932
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.3
28.8
224
998
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
28.7
1100
7855
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
28.5
1325
17387
A29
ICPC
General symptom/complaint other
1.5
28.1
891
6111
N05AH03
ATC
olanzapine; systemic
2.0
28.1
292
1460
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.7
28.0
596
3718
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.0
27.7
123
416
L03
ICPC
Low back symptom/complaint
1.4
27.7
1491
11337
WYA20
NOMESCO Finland
Home visit
2.5
27.3
177
728
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
75.5
26.8
30
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
7.3
26.7
39
54
C01CA01
ATC
etilefrine; systemic
4.0
26.3
73
182
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
26.1
25
*
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
4.9
25.9
57
118
M41.9
ICD-10 Finland
Scoliosis, unspecified
3.4
25.9
94
282
N05AX08
ATC
risperidone; systemic
1.6
25.7
584
3702
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.9
25.7
346
1890
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
25.5
402
2307
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
25.0
24
*
I95.9
ICD-10 Finland
Hypotension, unspecified
2.6
24.9
145
567
N04AA01
ATC
trihexyphenidyl; oral
26.3
24.8
34
13
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.5
24.7
316
5583
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
24.4
560
3558
R26
ICD-10 Finland
Abnormalities of gait and mobility
6.5
24.2
39
60
Z50.5
ICD-10 Finland
Speech therapy
3.3
24.2
91
279
H02AB02
ATC
dexamethasone; systemic
0.5
24.1
239
4571
N04BA07
ATC
foslevodopa and decarboxylase inhibitor; parenteral
+∞
24.0
23
*
N06DA02
ATC
donepezil; oral
1.6
24.0
549
3486
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
3.4
24.0
87
261
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.0
23.8
107
365
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.6
23.8
136
527
Z75.5
ICD-10 Finland
Holiday relief care
3.1
23.5
97
315
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
23.4
314
1714
R33
ICD-10 Finland
Retention of urine
1.5
23.1
678
4560
N04BX01
ATC
tolcapone; oral
+∞
22.9
22
*
SPAT1167
SPAT
Insertion of urinary catheter
1.9
22.8
278
1469
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.7
22.4
116
427
G72.8
ICD-10 Finland
Other specified myopathies
2.5
22.1
135
540
K11.72
ICD-10 Finland
Xerostomia
19.5
22.1
33
17
R1100, ,
SPAT
2.9
22.1
101
348
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
9.0
22.1
27
30
XKC03
NOMESCO Finland
Water cystometry
2.2
22.0
197
931
UKC02
NOMESCO Finland
Cystoscopy
1.4
21.9
1220
9277
Z29
ICPC
Social problem NOS
2.5
21.8
132
526
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.3
21.7
172
773
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
21.7
260
1366
AA1AA
NOMESCO Finland
Head X-ray examination
3.4
21.4
75
220
G04CA02
ATC
tamsulosin; oral
1.3
21.3
1950
15989
SPAT1172
SPAT
Guidance concerning hydration
2.1
20.9
198
957
F0234, G20,
ICD-10 Finland
+∞
20.8
20
*
N06AX03
ATC
mianserin; oral
1.9
20.8
281
1537
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.5
20.7
126
504
F05.9
ICD-10 Finland
Delirium, unspecified
2.1
20.4
191
918
S01.9
ICD-10 Finland
Open wound of head, part unspecified
2.5
20.4
127
513
L29
ICPC
Musculoskeletal sympt/complt other
1.6
20.2
514
3344
A03FA01
ATC
metoclopramide; systemic, rectal
0.7
20.2
655
9288
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
20.1
964
7134
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.2
20.1
170
786
G04BD04
ATC
oxybutynin; oral, transdermal
1.7
20.0
357
2121
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
2.7
19.8
103
381
P29
ICPC
Psychological sympt/compl other
2.0
19.6
223
1152
R25.8
ICD-10 Finland
Other and unspecified abnormal involuntary movements
6.0
19.5
34
57
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
19.4
883
6470
SPAT1304
SPAT
Counselling and guidance related to ageing
1.5
19.3
585
3956
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.2
19.2
162
748
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.6
19.2
107
410
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
19.1
1836
15103
G04BD07
ATC
tolterodine; oral
1.7
18.8
335
1989
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
18.7
207
1059
R63.4
ICD-10 Finland
Abnormal weight loss
1.8
18.7
278
1568
K02.1
ICD-10 Finland
Caries of dentine
1.3
18.6
2658
22979
L84
ICD-10 Finland
Corns and callosities
2.0
18.6
214
1110
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.0
18.5
204
1042
P03
ICPC
Feeling depressed
1.8
18.5
295
1697
R30.1
ICD-10 Finland
Vesical tenesmus
2.3
18.4
145
651
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
18.4
241
1306
C10AX09
ATC
ezetimibe; oral
0.7
18.4
551
7952
W06
ICD-10 Finland
Fall involving bed
3.0
18.2
81
275
J01MA02
ATC
ciprofloxacin; systemic
1.3
18.2
2374
20279
K03.66
ICD-10 Finland
Tooth plaque
1.6
18.1
413
2616
S00.0
ICD-10 Finland
Superficial injury of scalp
2.1
17.9
168
809
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.1
17.9
72
231
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
17.8
633
4424
Z02.7
ICD-10 Finland
Issue of medical certificate
1.6
17.6
425
2729
U07
ICPC
Urine symptom/complaint other
1.5
17.6
533
3603
N05BA01
ATC
diazepam; systemic, rectal
1.5
17.6
695
4957
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
17.6
488
3237
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.6
17.5
98
377
G04CB01
ATC
finasteride; oral
1.4
17.4
966
7314
M04AA01
ATC
allopurinol; systemic
0.7
17.0
540
7715
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.1
17.0
46
113
G25
ICD-10 Finland
Other extrapyramidal and movement disorders
7.5
17.0
24
32
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
13.2
16.9
29
22
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
16.9
827
6131
N03AX16
ATC
[U] pregabalin
1.3
16.8
1238
9787
G23.3
ICD-10 Finland
Multiple system atrophy, cerebellar type [MSA-C]
+∞
16.7
16
*
N03AX09
ATC
lamotrigine; oral
2.1
16.6
150
713
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.1
16.5
159
775
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
16.1
1203
9517
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
16.0
830
6207
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.1
16.0
66
215
Z3226
NOMESCO Finland
Physiotherapist
1.4
16.0
981
7540
R5140, ,
SPAT
2.6
15.9
94
372
L17
ICPC
Foot/toe symptom/complaint
1.3
15.7
1676
13904
R4110
NOMESCO Finland
Physiotherapy
1.3
15.5
1540
12659
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.3
15.5
55
1589
A06AX04
ATC
linaclotide; oral
4.8
15.4
34
71
M41.4
ICD-10 Finland
Neuromuscular scoliosis
38.1
15.4
19
5
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.4
15.3
822
6180
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
15.2
243
1401
U05
ICPC
Urination problems other
1.6
15.1
372
2399
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.4
15.1
661
4798
C01CA17
ATC
midodrine; oral
45.1
15.0
18
*
N05AN01
ATC
lithium; oral
2.5
15.0
91
365
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.8
14.9
219
1231
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.3
14.8
45
1407
S22.3
ICD-10 Finland
Fracture of rib
1.5
14.8
420
2799
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.5
14.8
438
2946
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
4.5
14.7
35
78
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.3
14.6
48
1442
Z43.5
ICD-10 Finland
Attention to cystostomy
2.9
14.6
66
227
AAG99
NOMESCO Finland
Other stereotactic intracranial operation
+∞
14.6
14
*
OAB73, ,
SPAT
4.0
14.6
41
104
U02
ICPC
Urinary frequency/urgency
1.4
14.5
776
5826
WYA20, ,
SPAT
3.0
14.5
64
217
C03CA01
ATC
furosemide; systemic
1.2
14.5
2394
20851
SPAT1244
SPAT
Occupational therapy
2.8
14.5
72
261
SPAT1050
SPAT
Extensive neurological examination
2.1
14.4
133
638
3010
Kela drug reimbursment
Midodrine
36.1
14.4
18
5
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.4
14.4
560
3979
N03AA03
ATC
primidone; oral
5.0
14.3
30
60
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.4
14.2
54
1511
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
6.2
14.2
24
39
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.8
14.2
68
242
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.2
14.1
120
558
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
14.0
744
5579
A01
ICPC
Pain general/multiple sites
1.4
14.0
553
3938
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.6
14.0
46
130
L01BC06
ATC
capecitabine; oral
0.3
14.0
44
1349
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
14.0
364
2380
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.7
13.9
73
272
N17
ICPC
Vertigo/dizziness
1.4
13.9
772
5830
L76
ICPC
Fracture: other
1.8
13.9
199
1111
G04CB02
ATC
dutasteride; oral
1.4
13.8
624
4555
H02AB06
ATC
prednisolone; systemic
0.8
13.8
2068
23757
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
13.7
745
5609
N05AX12
ATC
aripiprazole; systemic
2.4
13.6
95
406
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
3.2
13.6
52
162
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
6.5
13.6
22
34
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
2.8
13.6
65
231
F023, G20,
ICD-10 Finland
+∞
13.5
13
*
M40.1
ICD-10 Finland
Other secondary kyphosis
6.1
13.4
23
38
G25.1
ICD-10 Finland
Drug-induced tremor
6.1
13.4
23
38
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
2.5
13.3
84
343
AA1BG, ,
SPAT
2.3
13.3
97
423
S01.3
ICD-10 Finland
Open wound of ear
2.5
13.3
81
326
Z50.1
ICD-10 Finland
Other physical therapy
1.6
13.3
293
1843
R49.03
ICD-10 Finland
Atrophic dysphonia
2.3
13.2
95
412
T08
ICPC
Weight loss
2.2
13.2
115
540
Y94.0
ICD-10 Finland
Accident at home
2.1
13.1
126
615
N02CA01
ATC
dihydroergotamine; nasal, systemic
4.3
13.1
33
77
M03AX01
ATC
botulinum toxin; parenteral
3.9
13.0
38
99
R2130, ,
SPAT
2.4
13.0
84
347
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
2.9
13.0
59
204
N87
ICD-10 Finland
Dysplasia of cervix uteri
50.1
12.8
15
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
12.8
922
7235
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
3.3
12.8
47
143
H53.2
ICD-10 Finland
Diplopia
1.8
12.7
191
1083
N30
ICD-10 Finland
Cystitis
1.5
12.7
346
2286
EBA00
NOMESCO Finland
Extraction of tooth
1.2
12.6
1741
14809
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.0
12.6
53
175
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.7
12.6
239
1445
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
6.0
12.6
22
37
R44.3
ICD-10 Finland
Hallucinations, unspecified
3.3
12.5
47
145
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.3
12.5
90
391
SPAT1101
SPAT
Orthostatic test
1.6
12.5
316
2054
SPAT1262
SPAT
Handing over of treatment supplies
1.3
12.4
1055
8465
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
2.1
12.4
111
527
ICB01, ,
SPAT
3.2
12.4
47
146
3AX01, ,
NOMESCO Finland
5.0
12.4
26
52
SPAT1240
SPAT
Therapeutic discussion
1.6
12.4
320
2089
ZXY02
NOMESCO Finland
Neuropsychologist
4.4
12.3
30
68
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
12.3
503
3603
XQ855, ,
SPAT
2.4
12.3
80
332
G24
ICD-10 Finland
Dystonia
14.3
12.2
20
14
G31.0
ICD-10 Finland
Circumscribed brain atrophy
3.1
12.2
50
163
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
4.5
12.1
29
65
ZY000
NOMESCO Finland
Hospital inpatient
3.2
12.0
47
149
G24.5
ICD-10 Finland
Blepharospasm
5.2
12.0
24
46
S20.2
ICD-10 Finland
Contusion of thorax
1.6
12.0
277
1763
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
2.0
11.9
121
604
SPAT1042
SPAT
Guidance concerning balance maintenance
3.3
11.9
43
130
SPAT1360
SPAT
Extensive global examination
1.5
11.8
397
2740
RF120, ,
NOMESCO Finland
2.6
11.8
67
261
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
11.7
859
6753
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
3.1
11.7
48
157
G21
ICD-10 Finland
Secondary parkinsonism
65.1
11.6
13
*
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.8
11.6
161
892
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
11.5
555
4091
N04
ICPC
Restless legs
3.2
11.5
44
138
F0231, G20,
ICD-10 Finland
+∞
11.5
11
*
G22
ICD-10 Finland
Parkinsonism in diseases classified elsewhere
+∞
11.5
11
*
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
4.7
11.4
26
56
SCA01
NOMESCO Finland
Preventive oral health care, short
1.3
11.4
1076
8746
H02.3
ICD-10 Finland
Blepharochalasis
1.5
11.3
364
2490
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
2.2
11.3
96
447
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.8
11.3
178
1024
S09.9
ICD-10 Finland
Unspecified injury of head
2.1
11.3
98
461
R27.0
ICD-10 Finland
Ataxia, unspecified
3.8
11.3
34
91
G21.2
ICD-10 Finland
Secondary parkinsonism due to other external agents
35.1
11.3
14
*
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.4
11.2
615
4629
N06AB06
ATC
sertraline; oral
1.5
11.2
410
2877
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.4
11.2
77
328
E86
ICD-10 Finland
Volume depletion
1.8
11.2
178
1027
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.3
11.1
78
336
TKC20, ,
SPAT
2.8
11.0
54
195
M43.1
ICD-10 Finland
Spondylolisthesis
1.7
11.0
194
1152
N02BF02
ATC
pregabalin; oral
1.5
11.0
315
2104
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
1.8
11.0
155
863
XQ858, ,
SPAT
2.9
11.0
49
168
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
3.5
11.0
36
102
C10AA07
ATC
rosuvastatin; oral
0.8
11.0
1341
15852
TKC22
NOMESCO Finland
Catheterisation instruction
1.8
11.0
159
893
N03AF02
ATC
oxcarbazepine; oral
1.8
10.9
150
828
S72.1
ICD-10 Finland
Pertrochanteric fracture
1.8
10.9
170
975
S00.8
ICD-10 Finland
Superficial injury of other parts of head
2.1
10.9
98
467
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
10.9
113
568
M54
ICD-10 Finland
Dorsalgia
1.4
10.9
486
3537
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
0.4
10.9
49
1262
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
10.8
844
6690
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
10.8
646
4930
K08.3
ICD-10 Finland
Retained dental root
1.4
10.8
430
3069
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
4.6
10.7
25
55
IBC97
NOMESCO Finland
Other psychiatric aptitude assessment
60.1
10.6
12
*
F0289, G318,
ICD-10 Finland
60.1
10.6
12
*
R5210, ,
SPAT
8.0
10.6
23
29
S01
ICD-10 Finland
Open wound of head
2.3
10.5
74
319
K88
ICPC
Postural hypotension
2.3
10.5
75
326
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.0
10.5
115
591
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.9
10.4
46
157
A10BK03
ATC
empagliflozin; oral
0.7
10.4
321
4632
A08
ICPC
Swelling
1.5
10.3
356
2472
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.6
10.3
212
1312
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.8
10.3
141
779
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.3
10.3
658
5072
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
8.8
10.2
21
24
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
10.1
581
4405
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.6
10.1
57
222
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.5
10.1
308
2087
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
10.0
2919
26541
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
10.0
232
1480
N06AB05
ATC
paroxetine; oral
1.6
10.0
218
1371
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
2.0
9.9
106
539
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.8
9.9
140
781
N05CD07
ATC
temazepam; oral
1.3
9.9
735
5786
AA052, ,
NOMESCO Finland
16.7
9.9
15
9
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.6
9.9
237
1524
J01DB01
ATC
cefalexin; oral
1.2
9.8
4466
42196
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
9.8
196
1204
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.9
9.8
123
661
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
3.8
9.7
29
77
P01
ICPC
Feeling anxious/nervous/tense
1.5
9.7
260
1714
K90
ICPC
Stroke/cerebrovascular accident
1.6
9.7
205
1279
R49.08
ICD-10 Finland
Other specified dysphonia
2.0
9.7
105
538
SPAT1139
SPAT
Nutrition survey
1.6
9.7
192
1179
RF420, ,
NOMESCO Finland
2.3
9.6
68
294
K56.2
ICD-10 Finland
Volvulus
2.6
9.6
53
204
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
9.6
14
664
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.7
9.6
182
1104
R03BB04
ATC
tiotropium bromide; inhalant
0.7
9.6
363
5043
ZY010
NOMESCO Finland
Hospital outpatient
1.7
9.5
162
954
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
4.8
9.5
21
44
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
9.5
969
7933
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
9.5
128
704
A04AA02
ATC
granisetron; systemic, transdermal
0.6
9.4
130
2257
TJD20
NOMESCO Finland
Change of gastrostomy tube
3.4
9.4
33
98
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.3
9.4
858
6933
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
1.7
9.4
161
951
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.8
9.4
138
780
L02
ICPC
Back symptom/complaint
1.4
9.4
397
2865
M79.6
ICD-10 Finland
Pain in limb
1.2
9.3
2159
19200
R5599, ,
SPAT
3.5
9.3
31
89
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.7
9.3
246
3660
K07
ICPC
Swollen ankles/oedema
1.5
9.2
319
2216
M41.5
ICD-10 Finland
Other secondary scoliosis
4.0
9.2
25
62
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
9.2
3276
30202
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.3
9.2
534
4057
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.5
9.1
318
2213
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.3
9.1
540
4114
S28
ICPC
Limited function/disability (S)
2.4
9.1
58
240
WYA30, ,
SPAT
3.1
9.1
37
121
F03
ICD-10 Finland
Unspecified dementia
1.4
9.1
339
2392
WF002
NOMESCO Finland
Radical radiotherapy
0.6
9.1
159
2591
N05BA12
ATC
alprazolam; oral
1.4
9.0
441
3260
SPAT1260
SPAT
Consultation of another employee
1.3
9.0
917
7505
SFA10
NOMESCO Finland
One-surface restoration
1.2
9.0
2442
21999
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.2
9.0
8
419
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.3
9.0
555
4256
F0280, G318,
ICD-10 Finland
18.6
8.9
13
7
E87.6
ICD-10 Finland
Hypokalaemia
1.6
8.9
197
1243
G24.3
ICD-10 Finland
Spasmodic torticollis
2.7
8.9
45
166
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.5
8.8
53
213
SPAT1263
SPAT
Sampling
1.2
8.8
2168
19362
F02.80
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without additional symptoms
10.7
8.8
16
15
SCA02
NOMESCO Finland
Preventive oral health care
1.4
8.8
361
2592
G81.9
ICD-10 Finland
Hemiplegia, unspecified
2.3
8.8
62
269
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
8.7
640
5024
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
3.2
8.7
33
103
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.6
8.7
196
1242
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.1
8.7
80
386
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
1.8
8.7
127
717
L12
ICPC
Hand/finger symptom/complaint
1.3
8.7
761
6116
Z11
ICPC
Compliance/being ill problem
2.6
8.7
47
180
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.3
8.6
673
5326
L75
ICPC
Fracture: femur
2.0
8.6
93
476
WX212
NOMESCO Finland
Femoral plexus blockade
1.7
8.6
154
921
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.1
8.6
77
368
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
3.2
8.6
33
104
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.5
8.6
52
210
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.6
8.5
49
193
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
2.6
8.5
49
193
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
0.1
8.5
*
323
M10.9
ICD-10 Finland
Gout, unspecified
0.7
8.4
249
3622
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
2.3
8.4
58
249
N18
ICPC
Paralysis/weakness
1.8
8.4
128
732
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.6
8.4
177
1105
A99
ICPC
Disease/condition unspecnature/site
1.3
8.4
545
4210
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
1.8
8.4
118
660
F02.33
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly depression
+∞
8.3
8
*
359
Kela drug reimbursment
Mirabegroni
2.6
8.3
45
172
WX290
NOMESCO Finland
Other blockage of nerve
1.2
8.2
1745
15361
F05.8
ICD-10 Finland
Other delirium
2.3
8.2
60
264
G35
ICD-10 Finland
Multiple sclerosis
2.6
8.2
46
179
G04CA01
ATC
alfuzosin; oral
1.3
8.2
864
7094
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
0.2
8.2
6
358
N80
ICPC
Head injury other
1.8
8.2
106
578
F06.32
ICD-10 Finland
Organic depression
4.5
8.1
19
42
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
0.3
8.1
22
720
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.2
8.1
1187
10095
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
8.1
1596
13958
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.2
8.1
1163
9873
F02.8
ICD-10 Finland
Dementia in other specified diseases classified elsewhere
33.4
8.1
10
*
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
2.8
8.0
39
141
AA400
NOMESCO Finland
Electroconvulsive therapy
3.0
8.0
34
114
XKD03
NOMESCO Finland
Urethral pressure profilometry
1.8
8.0
116
654
34200
ICD-8 Finland
Paralysis agitans, Parkinsonismus
22.0
8.0
11
5
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.3
8.0
59
261
L21.0
ICD-10 Finland
Seborrhoea capitis
2.3
8.0
58
255
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
0.6
8.0
141
2292
D64.9
ICD-10 Finland
Anaemia, unspecified
1.3
8.0
750
6078
A03FA02
ATC
cisapride; oral, rectal
1.4
7.8
410
3066
U29
ICPC
Urinary symptom/complaint other
1.6
7.8
180
1149
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.5
7.8
247
1689
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.5
7.8
45
178
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.5
7.8
46
184
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.1
7.8
68
323
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.4
7.7
39
952
S72.9
ICD-10 Finland
Fracture of femur, part unspecified
2.8
7.7
37
133
SFE01
NOMESCO Finland
Carriage renovation
3.6
7.7
24
66
R4190
NOMESCO Finland
Nutritional therapy
1.7
7.7
148
903
WX110
NOMESCO Finland
Infiltration anesthesia
1.2
7.7
3464
32320
R5599
NOMESCO Finland
Other rehabilitation service
1.7
7.7
133
789
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.4
7.7
288
2034
Z75.0
ICD-10 Finland
Medical services not available in home
3.9
7.7
22
57
R4160, ,
SPAT
3.1
7.7
30
96
N06AX12
ATC
bupropion; oral
1.7
7.6
147
899
A10BJ06
ATC
semaglutide; parenteral
0.5
7.6
79
1483
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.1
7.6
*
295
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
7.6
556
4366
WF004
NOMESCO Finland
Palliative radiotherapy
0.4
7.6
29
798
SPAT1125
SPAT
Stoma care and guidance
1.8
7.6
114
651
3339X
ICD-9 Finland
Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders
25.0
7.6
10
*
I95.8
ICD-10 Finland
Other hypotension
2.7
7.6
39
146
S32.1
ICD-10 Finland
Fracture of sacrum
2.5
7.5
45
181
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
7.5
679
5472
H51.1
ICD-10 Finland
Convergence insufficiency and excess
6.1
7.5
19
31
R31
ICD-10 Finland
Unspecified haematuria
1.3
7.5
698
5646
M01AC06
ATC
meloxicam; systemic, rectal
1.2
7.5
1764
15643
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
7.4
1652
14581
G21.4
ICD-10 Finland
Vascular parkinsonism
80.2
7.4
8
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.1
7.4
69
336
NFB10
NOMESCO Finland
Primary partial prosthetic replacement of hip joint not using cement, other or unspecified
3.1
7.4
29
93
G04BD10
ATC
darifenacin; oral
2.5
7.4
45
183
N05CF01
ATC
zopiclone; oral
1.2
7.4
1807
16073
R03AK03
ATC
[U] fenoterol and ipratropium bromide
0.6
7.4
168
2574
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.5
7.4
58
1192
A04AA55
ATC
palonosetron, combinations; systemic
0.4
7.3
28
771
I10
ICD-10 Finland
Essential (primary) hypertension
0.9
7.3
3584
38041
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.4
7.3
36
885
N04C02, ,
ATC
+∞
7.3
7
*
AA5FN, ,
NOMESCO Finland
+∞
7.3
7
*
R43.0
ICD-10 Finland
Anosmia
2.6
7.3
39
149
RF433, ,
NOMESCO Finland
9.4
7.3
14
15
OAB43, ,
SPAT
0.7
7.3
180
2710
OAB50, ,
SPAT
1.3
7.2
430
3278
G72.9
ICD-10 Finland
Myopathy, unspecified
2.4
7.2
46
191
Z93.5
ICD-10 Finland
Cystostomy status
3.3
7.2
26
79
G24.1
ICD-10 Finland
Idiopathic familial dystonia
15.7
7.2
11
7
UGC12
NOMESCO Finland
Flexible bronchoscopy
0.7
7.2
261
3654
AAG10
NOMESCO Finland
Stereotactic intracranial destruction of nucleus or nerve tract
30.0
7.1
9
*
N04AB02
ATC
orphenadrine (chloride); systemic
20.0
7.1
10
5
R4120
NOMESCO Finland
Occupational therapy
1.4
7.1
297
2140
L86
ICPC
Back syndrome with radiating pain
1.4
7.1
287
2056
SFA20
NOMESCO Finland
Two-surface restoration
1.2
7.1
2475
22606
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
7.1
1145
9817
N06AA12
ATC
doxepin; systemic
1.4
7.1
260
1831
N06AA06
ATC
trimipramine; systemic
1.8
7.1
106
605
Z10.1
ICD-10 Finland
Routine general health check-up of inhabitants of institutions
6.0
7.1
18
30
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
5.6
7.0
19
34
C08CA01
ATC
amlodipine; oral
0.9
7.0
2059
22718
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
8.8
7.0
14
16
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.4
7.0
255
1793
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
1.6
7.0
166
1068
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
3.1
7.0
28
91
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.0
7.0
73
371
SPAT1127
SPAT
Enema
2.2
7.0
55
251
U01
ICPC
Dysuria/painful urination
1.4
7.0
332
2447
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
2.3
7.0
52
232
NF3AA
NOMESCO Finland
Femur X-ray examination
1.7
7.0
130
789
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
4.4
6.9
17
39
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
6.9
1296
14826
S63.1
ICD-10 Finland
Dislocation of finger
1.9
6.9
79
414
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.3
6.9
713
5837
RF410, ,
NOMESCO Finland
2.2
6.9
57
265
F0029, G308,
ICD-10 Finland
3.7
6.9
21
57
PA2AD
NOMESCO Finland
CT angiography of brain
2.5
6.9
42
171
OAA80, ,
SPAT
0.4
6.9
33
820
AA3AD
NOMESCO Finland
CT of face
2.3
6.9
47
202
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.3
6.8
48
209
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
1.9
6.8
74
382
N05AF03
ATC
chlorprothixene; systemic
1.8
6.7
88
482
ZXA10
NOMESCO Finland
Bilateral
1.2
6.7
1005
8550
Z60.8
ICD-10 Finland
Other problems related to social environment
3.1
6.7
27
88
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.8
6.7
1086
12585
M03BX02
ATC
tizanidine; oral
1.2
6.7
2719
25076
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
1.8
6.7
94
527
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1.8
6.7
90
498
L01CA04
ATC
vinorelbine; systemic
0.1
6.6
*
268
S97
ICPC
Chronic ulcer skin
1.3
6.6
391
2979
SPAT1104
SPAT
Monitoring of emergency patient
1.4
6.6
338
2519
B03XA02
ATC
darbepoetin alfa; parenteral
0.4
6.6
30
763
SPAT1138
SPAT
Guidance concerning bowel function
1.8
6.6
84
457
M05BA04
ATC
alendronic acid; oral
1.3
6.6
506
3999
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
2.7
6.6
34
128
SPAT1252
SPAT
Overall medication plan or its review
1.3
6.5
399
3056
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
3.8
6.5
19
50
A02BC05
ATC
esomeprazole; systemic
1.2
6.5
2048
18539
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
1.7
6.5
117
705
B03BA03
ATC
hydroxocobalamin; parenteral
1.3
6.4
354
2671
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.6
6.4
143
909
F32
ICD-10 Finland
Depressive episode
1.6
6.4
145
925
R39.1
ICD-10 Finland
Other difficulties with micturition
1.5
6.4
185
1246
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
1.9
6.4
72
377
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
1.7
6.3
109
648
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.6
6.3
141
2168
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
0.8
6.3
404
5184
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
2.8
6.3
30
108
S20
ICPC
Corn/callosity
1.7
6.3
118
718
T90
ICPC
Diabetes non-insulin dependent
0.8
6.3
1121
12891
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
5.5
6.3
17
31
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
3.2
6.3
24
76
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.6
6.3
115
1847
R40.0
ICD-10 Finland
Somnolence
3.3
6.3
22
66
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.6
6.3
137
2114
IHZ05, ,
SPAT
1.9
6.2
78
422
R1410, ,
SPAT
7.0
6.2
14
20
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.7
6.2
147
2229
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.6
6.2
83
1443
L03AA13
ATC
pegfilgrastim; parenteral
0.5
6.2
70
1276
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
0.2
6.2
*
255
R40.2
ICD-10 Finland
Coma, unspecified
2.1
6.2
54
258
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
6.1
1615
14413
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.5
6.1
179
1208
L99
ICPC
Musculoskeletal disease other
1.7
6.1
107
640
SPAT1246
SPAT
Screening of depression or other psychiatric problem
1.7
6.1
103
610
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.4
6.1
213
1489
F21, ,
ICPC
2.0
6.1
58
286
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
4.1
6.1
16
39
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.6
6.1
123
764
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
8.6
6.0
12
14
JN4BD
NOMESCO Finland
Extensive body CT
0.8
6.0
366
4732
R74
ICPC
Upper respiratory infection acute
0.8
6.0
705
8436
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
1.7
6.0
112
681
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
2.1
6.0
56
274
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
121
152
8.10
89.87
2.1
1.2
127.23
126.97
nmol/l
0.00
70
111
2711
19367
1.71
88.53
2.6
2.3
247.85
218.33
u/l
1.00
2575
18182
2654
19098
1.68
82.50
1.9
1.8
18.67
20.04
nmol/l
5.12
2324
16014
3515
27665
1.63
73.21
2.5
2.3
89.28
93.63
pmol/l
7.45
2160
14796
4384
37045
1.63
63.00
7.0
5.4
3608.02
2127.30
e6/l
0.51
87
616
3823
31363
1.57
61.43
6.0
7.6
1.21
1.21
mmol/l
4.09
3323
26881
1804
12467
1.63
60.99
1.9
1.8
1157.12
1159.50
nmol/l
0.04
1394
9279
3442
28214
1.50
50.55
5.6
6.9
1.21
1.21
mmol/l
0.84
3168
25866
1661
11794
1.56
47.81
2.1
2.0
—
—
—
0
0
156
442
3.59
46.60
1.0
1.0
263.79
326.65
ng/l
2.32
113
299
156
443
3.59
46.44
1.0
1.0
30.80
43.50
ng/l
4.64
108
296
156
444
3.58
46.29
1.0
1.0
642.29
700.53
ng/l
0.94
109
293
303
1251
2.50
46.24
1.3
1.3
519.68
586.97
mg/l
1.49
290
1186
1308
8884
1.60
45.25
2.0
1.9
—
—
—
0
0
4273
37373
1.46
39.65
6.0
5.1
2.20
1.60
0.38
13
55
264
1098
2.47
39.63
1.3
1.2
3.81
3.90
mmol/l
0.73
249
1033
258
1065
2.48
39.36
1.4
1.3
3.95
32.55
e6/l
2.69
203
786
3447
29023
1.42
39.06
5.3
4.4
5.89
3.18
estimate
0.36
742
6514
259
1075
2.47
39.05
1.4
1.4
604.52
1068.44
e6/l
0.54
218
846
1768
13211
1.47
38.24
1.8
1.8
410.77
27714101.71
pmol/l
8.22
1462
10659
3404
28677
1.42
37.94
5.2
4.3
0.00
0.00
estimate
0.23
706
6297
3457
29220
1.41
37.70
5.3
4.4
0.01
0.23
estimate
0.70
700
6037
116
320
3.68
36.11
1.1
1.1
1.83
14.50
nmol/l
1.90
14
73
1180
8252
1.53
34.73
2.1
1.9
—
—
—
0
0
2504
20563
1.37
29.62
4.2
3.8
73.42
99.78
e6/l
0.47
1962
16051
3240
27761
1.35
28.75
4.1
5.2
34.90
34.55
g/l
2.86
2998
25827
2799
23477
1.35
28.49
2.6
2.3
—
—
—
0
0
2559
21196
1.35
28.18
5.5
4.5
0.08
0.27
estimate
0.74
591
5169
2113
17011
1.37
27.86
2.4
2.5
2.76
2.97
mg/l
4.01
1783
14583
690
4479
1.61
27.67
2.0
1.8
—
—
—
0
0
4194
37527
1.36
27.24
4.4
4.3
15.49
15.11
pmol/l
17.76
3784
33564
2672
22367
1.34
27.06
4.9
4.4
156.23
116.85
e6/l
0.69
1995
16454
2189
17780
1.36
27.06
4.1
3.6
0.45
0.50
e6/l
0.46
1676
13436
2825
23959
1.33
25.67
4.9
4.5
51.38
90.15
ng/l
1.27
2331
19267
2051
16627
1.35
25.21
4.0
3.6
21.28
143.92
estimate
0.49
13
107
2859
24337
1.32
25.10
2.4
2.4
76.31
79.66
nmol/l
9.07
2493
21320
1438
11112
1.38
23.69
3.7
3.3
1.29
1.41
e6/l
0.15
820
6208
103
349
2.98
23.17
1.0
1.0
273.10
287.67
mg/l
1.37
93
312
3874
34616
1.32
23.11
5.3
5.4
6.59
6.90
mmol/l
18.68
3755
33058
1619
12853
1.35
22.24
5.6
4.7
1.02
1.13
kg/l
0.46
1118
8831
2728
23378
1.30
21.57
3.1
3.2
145.72
159.23
ug/l
1.52
2457
21312
1685
20504
0.76
20.40
1.8
2.0
1.17
1.30
mmol/l
14.65
1383
16672
1730
20964
0.76
20.28
3.3
3.5
51.75
52.20
mg/l
0.01
1167
13718
2021
16753
1.31
20.10
5.4
4.5
0.00
0.00
estimate
1.34
624
5596
1785
14629
1.31
19.08
3.1
2.9
4.70
4.54
e6/l
0.30
1642
13338
1768
21197
0.77
18.65
3.2
3.5
7.41
7.18
mmol/l
1.53
1454
17504
98
371
2.67
18.03
2.8
2.3
—
—
—
0
0
1296
10235
1.34
17.81
3.9
3.5
2.26
2.01
e6/l
0.49
670
5305
2435
20926
1.27
17.58
2.5
3.6
2.34
2.35
mmol/l
1.72
2177
18741
1806
21436
0.78
17.15
3.9
4.3
6.35
9.57
mg/mmol
4.42
1172
13542
4857
45479
1.32
16.77
5.8
5.4
1.93
2.06
mu/l
11.01
4443
40983
469
3119
1.54
16.69
2.4
2.5
20.06
21.01
au/ml
0.08
30
223
1670
13767
1.29
16.62
4.9
4.1
0.33
0.43
0.13
24
194
99
393
2.54
16.59
1.2
1.2
1.91
2.28
mmol/l
4.30
87
370
1578
12931
1.30
16.41
2.5
3.2
2.45
2.46
mmol/l
9.64
1399
11552
515
3510
1.51
16.35
1.5
1.5
—
—
—
0
0
433
2844
1.56
16.29
1.3
1.3
68.82
61.54
au/ml
0.24
22
201
146
693
2.13
16.22
5.3
4.2
372.23
339.86
umol/l
1.79
132
591
390
2517
1.59
15.83
1.9
2.2
640.41
705.16
ug/l
0.13
362
2405
4216
38945
1.26
15.16
4.4
4.7
12.43
14.66
mm/h
18.86
3886
35937
1718
14417
1.27
14.41
4.8
4.0
0.14
0.26
estimate
0.45
553
4867
1705
14379
1.26
13.54
4.0
3.4
0.17
0.06
1.09
72
526
112
527
2.15
12.81
1.3
1.3
—
—
—
0
0
68
256
2.67
12.77
1.2
1.4
—
—
—
0
0
1500
12545
1.26
12.66
3.5
3.2
561.08
533.86
mosm/kgh2o
5.87
1339
11019
43
130
3.32
11.87
2.2
2.1
—
—
—
0
0
5147
49137
1.28
11.63
23.1
20.6
28.15
28.24
mg/l
0.07
4566
42022
43
132
3.27
11.60
2.2
2.1
—
—
—
0
0
3305
30356
1.19
10.14
17.2
20.1
1.33
1.36
inr
3.20
2826
25652
1372
11611
1.23
10.06
1.7
1.7
1.40
1.55
mg/l
0.92
1108
9202
733
5785
1.30
9.64
2.4
2.2
0.00
0.00
estimate
0.78
102
1069
94
466
2.03
9.49
1.1
1.1
—
4.15
—
0
8
583
4467
1.34
9.46
5.3
6.7
25.66
24.44
mmol/l
13.71
553
4286
4443
42080
1.20
8.99
6.7
8.8
80.26
82.62
u/l
2.17
4164
39743
1264
10736
1.22
8.81
2.2
3.1
0.82
0.81
mmol/l
2.66
1159
10029
65
290
2.25
8.61
1.5
1.5
5.44
6.59
u/l
0.59
53
246
64
284
2.27
8.59
1.2
1.1
339.11
312.95
mg/l
0.13
53
244
691
5535
1.28
8.07
2.6
2.7
0.60
0.48
e6/l
0.62
661
5353
2990
27540
1.17
8.02
5.2
6.1
0.58
0.63
e9/l
21.42
2511
23126
3043
28079
1.16
7.93
5.4
6.2
1.79
1.83
e9/l
0.20
2615
24150
1441
12506
1.20
7.92
4.7
4.5
184.91
463.92
ng/l
2.81
1252
10995
582
7327
0.77
7.87
2.8
4.2
9.89
22.74
ug/l
1.52
452
6122
65
302
2.16
7.84
1.2
1.1
49.93
46.74
mg/l
0.10
51
253
3000
27673
1.16
7.80
5.3
6.1
0.04
0.04
e9/l
13.01
2515
23265
1329
11464
1.20
7.79
2.3
2.8
11.65
11.97
umol/l
0.90
1202
10595
77
384
2.02
7.73
1.1
1.1
—
—
—
0
0
988
8297
1.23
7.60
5.3
7.1
1.70
0.92
mmol/l
8.29
847
6762
58
262
2.23
7.51
1.1
1.1
—
—
—
0
0
615
4921
1.28
7.24
1.7
1.7
—
—
—
0
0
612
4900
1.28
7.17
1.9
2.4
399.34
382.61
nmol/l
1.19
548
4519
371
4854
0.75
6.66
1.3
1.3
—
—
—
0
0
2816
26050
1.15
6.61
2.7
3.0
—
—
estimate
—
0
0
2053
18569
1.16
6.60
2.5
2.7
55.00
65.42
u/l
1.70
1887
17110
1243
10803
1.19
6.58
2.3
2.7
2.23
2.24
g/l
0.37
1118
9911
983
8386
1.20
6.38
5.3
7.2
11.98
11.91
kpa
0.15
936
8044
983
8389
1.20
6.35
5.3
7.2
5.19
5.06
kpa
3.19
938
8048
3046
28401
1.14
6.22
5.5
6.2
0.18
0.20
e9/l
10.94
2607
24228
46
205
2.25
6.22
1.4
1.2
0.53
0.53
ratio
0.03
25
124
3299
31026
1.14
5.68
7.1
9.5
4.34
4.36
e9/l
0.16
2803
26591
849
7220
1.20
5.67
8.5
8.4
—
—
—
0
0
1143
9991
1.18
5.58
1.3
1.3
1.35
1.66
u/ml
0.48
273
2464
260
1914
1.37
5.57
3.1
4.3
3.86
3.92
mmol/l
1.36
255
1893
1385
15521
0.86
5.52
2.5
3.1
337.47
361.95
umol/l
14.35
1137
13311
2406
22209
1.14
5.49
3.0
3.4
1440.77
1822.10
ng/l
2.90
2086
19584
55
277
1.99
5.49
1.1
1.1
—
—
—
0
0
745
6282
1.21
5.44
2.0
2.6
66.00
65.84
g/l
0.22
654
5669
458
3683
1.26
5.21
2.6
2.6
0.66
0.62
%
1.08
458
3667
2716
25366
1.13
4.97
5.4
6.3
60.21
58.87
%
6.91
2554
24053
874
7540
1.19
4.96
5.5
7.4
95.36
95.23
%
0.23
838
7282
343
2678
1.30
4.95
2.6
3.3
4.42
4.34
pmol/l
0.77
292
2343
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
49
247
1.99
4.92
1.2
1.1
—
—
—
0
0
163
2310
0.70
4.90
1.9
2.1
3.15
3.42
ratio
3.50
137
1896
235
1747
1.36
4.78
3.5
3.7
1.68
1.96
index
0.36
115
918
5256
51217
1.17
4.78
28.1
25.4
139.76
139.58
mmol/l
5.80
5175
50160
192
1386
1.40
4.68
1.4
1.3
—
—
—
0
0
192
1386
1.40
4.68
1.4
1.3
—
—
—
0
0
1139
10089
1.16
4.63
2.3
2.8
21.21
21.45
%
0.23
1029
9312
452
3684
1.24
4.60
4.4
4.2
47.07
46.10
%
0.37
444
3629
5257
51264
1.17
4.56
28.3
25.6
3.98
4.01
mmol/l
15.99
5172
50148
28
118
2.38
4.38
1.0
1.1
—
—
—
0
0
105
1580
0.66
4.37
1.7
1.8
3.08
3.34
mmol/l
2.25
80
1163
57
317
1.81
4.31
1.4
2.0
—
—
—
0
0
1600
14577
1.13
4.26
4.0
4.4
83.11
83.57
%
0.32
1567
14281
612
5186
1.20
4.26
3.2
4.1
1.23
1.22
mmol/l
0.63
512
4467
702
6025
1.19
4.23
3.0
3.1
4.43
4.42
kpa
0.04
682
5841
804
6984
1.17
4.20
2.0
2.5
61.53
68.08
e9/l
7.53
589
5183
192
1415
1.37
4.18
5.4
6.8
10.33
11.36
mmol/l
3.80
177
1274
192
1415
1.37
4.18
5.4
6.8
105.27
104.98
mmol/l
0.42
177
1275
31
142
2.19
4.04
1.1
1.1
—
—
—
0
0
298
2353
1.28
4.01
3.1
3.9
1.23
1.41
mmol/l
2.96
289
2312
792
6899
1.17
4.00
5.9
7.9
121.67
119.73
g/l
1.96
770
6747
312
2480
1.27
3.98
2.0
1.9
—
—
—
0
0
188
1396
1.36
3.92
1.6
2.4
29.46
33.47
umol/l
0.85
159
1231
29
131
2.22
3.91
1.1
1.1
—
—
—
0
0
14
43
3.26
3.90
2.6
1.7
16.97
17.79
umol/l
0.12
14
43
360
2926
1.24
3.80
2.2
2.2
0.00
0.32
estimate
0.53
77
805
2746
25921
1.11
3.78
5.5
6.5
24.76
25.62
%
3.60
2565
24362
283
2240
1.28
3.75
1.2
1.3
—
—
—
0
0
70
1108
0.63
3.74
4.1
4.8
1134.80
2627.56
iu/ml
—
10
169
252
3201
0.78
3.72
1.8
1.9
1.46
1.40
g/l
0.10
221
2882
140
1931
0.72
3.68
1.8
1.7
—
—
—
0
0
92
1367
0.67
3.66
1.2
1.3
—
—
—
0
0
30
142
2.12
3.64
1.1
1.1
—
—
—
0
0
111
1580
0.70
3.53
1.5
1.5
—
—
—
0
0
329
2673
1.24
3.51
2.0
2.0
—
—
—
0
0
29
138
2.11
3.48
1.1
1.1
—
—
—
0
0
15
379
0.39
3.45
1.1
1.1
—
—
—
0
0
403
3352
1.22
3.45
4.7
3.7
1.02
1.02
ratio
2.46
364
3041
2096
19582
1.11
3.45
4.9
5.1
22.21
22.28
%
0.08
1121
10814
3943
38002
1.10
3.40
30.1
27.2
330.99
331.15
g/l
0.55
3908
37720
193
2506
0.76
3.40
2.4
3.4
475.02
2643.46
u/ml
1.18
159
2164
55
899
0.61
3.40
1.1
1.1
—
—
—
0
0
2578
24349
1.10
3.39
5.7
6.3
4.35
3.80
ug/l
0.21
2306
21758
18
71
2.54
3.29
1.1
1.2
—
—
—
0
0
45
255
1.77
3.28
1.7
1.6
4.92
116.69
u/l
0.93
13
82
4375
45026
0.90
3.25
4.2
4.7
1.16
1.27
mmol/l
27.85
3886
40071
3178
30353
1.10
3.24
3.3
3.4
44.99
57.87
u/l
9.87
2895
27719
16
60
2.67
3.22
1.1
1.1
—
—
—
0
0
4569
46910
0.90
3.21
4.9
5.5
1.43
1.43
mmol/l
0.48
4118
42334
710
6242
1.16
3.19
5.1
7.0
1.28
1.38
mmol/l
1.96
698
6104
813
7217
1.15
3.19
3.2
3.7
5.87
5.81
kpa
1.12
787
7027
361
4319
0.83
3.12
1.4
1.5
—
—
—
0
0
82
551
1.49
3.06
2.4
2.0
1.38
1.23
u/field
0.12
34
290
400
3370
1.20
3.03
3.5
3.4
25.58
25.09
mmol/l
2.39
381
3263
363
3033
1.21
3.00
4.7
5.0
0.90
0.86
%
1.52
349
2876
4615
47312
0.90
3.00
5.0
5.6
4.29
4.37
mmol/l
6.65
4184
43059
185
1433
1.30
2.97
1.6
1.6
—
—
—
0
0
3220
30846
1.09
2.97
4.6
6.8
11.88
12.60
umol/l
2.45
3046
29394
15
57
2.64
2.96
1.1
1.0
—
—
—
0
0
698
6166
1.15
2.94
2.4
2.5
6.07
7.00
ug/l
1.07
538
5355
1565
14507
1.11
2.93
2.3
2.6
—
—
—
0
0
95
668
1.43
2.84
1.6
1.5
—
—
—
0
0
674
5959
1.15
2.82
3.4
3.2
194.43
244.31
ng/l
2.97
621
5519
157
2037
0.76
2.81
2.7
4.3
75.41
92.43
u/ml
0.25
152
1954
515
4465
1.17
2.81
3.0
3.2
128.31
127.20
g/l
0.64
501
4332
119
872
1.37
2.81
2.6
2.4
1.21
1.20
mmol/l
0.89
119
861
30
158
1.90
2.79
1.2
1.1
—
—
—
0
0
1114
10171
1.12
2.77
2.0
2.0
29.75
30.04
s
0.79
1086
9875
213
1699
1.26
2.74
1.9
2.4
127.93
126.59
g/l
0.37
178
1306
5275
51798
1.12
2.73
29.7
27.8
78.06
85.69
umol/l
51.10
5214
51008
388
3295
1.19
2.72
4.6
4.9
1.46
1.57
%
2.60
373
3128
736
6565
1.14
2.70
4.7
3.9
—
—
—
0
0
30
537
0.56
2.69
1.3
1.4
—
—
—
0
0
120
888
1.36
2.68
2.6
2.4
4.05
4.11
mmol/l
0.73
120
877
120
888
1.36
2.68
2.6
2.4
106.56
105.58
mmol/l
1.40
120
877
579
5089
1.15
2.64
2.8
3.9
81.51
98.56
ng/l
4.90
472
4280
38
221
1.72
2.60
1.1
1.0
1.06
1.23
u/l
1.21
13
102
697
7799
0.88
2.60
1.3
1.3
8.55
13.84
u/ml
1.39
241
2686
28
148
1.90
2.60
1.0
1.1
—
—
—
0
0
320
2683
1.20
2.60
2.1
2.4
0.59
1.03
g/l
2.11
267
2263
782
7024
1.13
2.58
3.2
3.7
2.40
1.77
mmol/l
6.31
706
6075
455
3936
1.17
2.57
3.0
3.7
2.21
1.93
mmol/l
1.09
330
2882
133
1738
0.76
2.55
2.3
2.7
1.51
1.79
mg/l
4.59
114
1528
6
11
5.46
2.54
1.0
1.1
—
—
—
0
0
363
3091
1.19
2.49
1.9
1.9
2.51
2.48
ug/l
0.02
293
2716
85
1182
0.72
2.47
1.3
1.6
—
—
—
0
0
17
76
2.24
2.43
1.1
1.2
—
—
—
0
0
242
1993
1.22
2.38
2.3
2.4
0.00
0.00
g/l
-0.00
221
1847
15
64
2.35
2.38
1.1
1.1
—
—
—
0
0
14
58
2.42
2.36
1.9
1.6
—
—
—
0
0
22
413
0.53
2.36
1.2
1.2
—
—
—
0
0
77
1077
0.71
2.33
1.4
1.5
1948.88
2931.71
e6/l
0.53
56
753
115
1510
0.76
2.31
2.5
3.2
1173.66
889.22
u/ml
0.12
103
1377
5284
51986
1.11
2.31
33.8
31.1
236.55
238.85
e9/l
1.83
5179
50665
5284
51987
1.11
2.30
33.7
31.0
91.95
91.91
fl
0.23
5224
51212
5284
51989
1.11
2.29
33.8
31.1
4.32
4.38
e12/l
16.63
5149
50451
5284
51990
1.11
2.29
34.2
31.7
38.88
39.55
%
13.85
5225
51193
68
967
0.70
2.28
1.5
1.5
98524.08
67059.36
e6/l
0.52
36
543
5284
51995
1.11
2.27
34.1
31.3
130.11
132.39
g/l
24.35
5228
51251
584
6541
0.88
2.23
4.8
6.8
10.56
11.33
mmol/l
1.61
532
6226
5283
51998
1.11
2.21
33.8
31.1
6.85
6.96
e9/l
2.04
5152
50449
173
1388
1.25
2.19
1.2
1.2
—
—
—
0
0
86
1166
0.73
2.17
2.9
3.8
2.28
1.64
%
0.38
70
1022
52
769
0.67
2.16
1.1
1.4
174.80
161.41
au/ml
0.39
15
227
526
4664
1.14
2.15
6.2
8.8
1.28
1.29
%
0.13
519
4634
99
1312
0.75
2.15
1.2
1.3
2.40
6.16
u/ml
2.28
13
199
63
436
1.45
2.13
1.7
1.8
—
—
—
0
0
509
4512
1.14
2.10
6.4
9.1
0.69
0.63
%
2.81
503
4481
105
1371
0.76
2.06
1.2
1.2
96.63
37.78
u/ml
—
6
66
54
784
0.69
2.06
1.1
1.2
—
108.03
—
0
7
173
1400
1.24
2.05
1.2
1.2
—
—
—
0
0
337
2905
1.17
2.05
2.1
2.4
2.88
2.92
g/l
0.28
294
2589
263
2223
1.19
2.02
2.2
2.3
0.06
0.04
g/l
0.22
234
1978
136
1072
1.27
2.02
1.8
1.6
—
30.85
—
0
5
207
1711
1.22
2.02
1.2
1.2
—
—
—
0
0
100
1308
0.76
2.00
1.3
1.2
3.05
2.98
u/ml
0.02
11
127
10
38
2.63
2.00
1.2
1.1
—
—
—
0
0
23
402
0.57
1.98
1.4
1.1
—
—
—
0
0
523
4664
1.13
1.98
6.4
9.0
93.69
93.77
%
0.11
518
4647
43
280
1.54
1.97
1.1
1.2
—
—
—
0
0
518
4621
1.13
1.95
3.1
3.9
5.19
5.13
kpa
0.83
480
4390
4759
48454
0.92
1.93
5.8
6.5
2.43
2.49
mmol/l
4.57
4300
43946
11
45
2.45
1.92
1.1
1.2
22.73
11.49
u/l
0.31
11
45
49
712
0.69
1.90
1.1
1.2
314.12
296.23
u/ml
0.15
30
426
87
1148
0.75
1.87
1.2
1.2
1.38
4.73
u/ml
—
6
80
5
139
0.36
1.87
6.0
7.6
6.68
5.44
kpa
—
5
139
252
2140
1.19
1.86
2.2
2.3
0.00
0.00
g/l
0.50
221
1855
281
2412
1.17
1.83
3.4
4.1
25.22
24.81
mmol/l
1.96
239
2176
39
586
0.66
1.81
1.0
1.2
175.39
191.39
miu/ml
0.13
11
174
357
3125
1.15
1.81
2.0
2.4
7.13
7.47
g/l
3.64
314
2806
32
199
1.61
1.79
2.4
2.1
42.99
53.60
umol/l
1.11
23
169
354
4033
0.87
1.79
2.9
2.8
10.02
10.65
g/l
1.91
310
3693
356
3119
1.15
1.78
2.0
2.4
3.58
3.73
g/l
1.47
314
2803
3976
38805
1.07
1.76
27.5
25.6
13.76
13.96
%
17.76
3926
38245
356
3125
1.15
1.74
2.0
2.4
4.11
4.18
g/l
1.12
314
2811
11
229
0.48
1.69
1.4
1.9
—
—
—
0
0
310
2703
1.15
1.68
2.0
2.4
10.09
10.27
g/l
0.38
264
2353
11
228
0.48
1.67
1.2
1.9
—
—
—
0
0
11
228
0.48
1.67
1.2
1.9
—
—
—
0
0
225
2634
0.85
1.65
1.7
1.6
19.62
19.23
iu/ml
—
6
62
52
367
1.42
1.65
1.6
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
220
2578
0.85
1.64
2.3
2.8
0.40
0.34
iu/ml
1.40
130
1435
58
425
1.37
1.51
1.1
1.2
102.57
99.24
pmol/l
0.22
58
425
71
927
0.76
1.48
1.1
1.2
—
44.96
—
0
102
28
178
1.58
1.48
1.2
1.1
—
—
—
0
0
64
479
1.34
1.47
1.3
1.4
—
—
—
0
0
18
305
0.59
1.46
1.2
1.7
—
—
—
0
0
18
305
0.59
1.46
1.2
1.7
—
—
—
0
0
18
305
0.59
1.46
1.2
1.7
—
—
—
0
0
18
305
0.59
1.46
1.2
1.7
—
—
—
0
0
6
22
2.73
1.43
2.2
1.5
417.60
367.24
nmol/l
—
6
22
106
853
1.25
1.42
1.7
2.1
28.80
25.12
mg/l
0.28
29
290
777
8356
0.92
1.41
1.3
1.3
27.78
39.27
iu/ml
2.04
221
2476
20
118
1.70
1.41
1.3
1.3
106.31
109.91
%
0.15
13
103
24
149
1.61
1.40
1.4
1.5
13.88
17.16
pmol/l
2.15
17
118
595
5464
1.10
1.39
2.0
2.1
197.86
164.70
ug/g
1.22
482
4274
102
1260
0.81
1.37
1.1
1.3
24.24
39.97
u/l
1.21
89
1088
35
239
1.47
1.36
1.1
1.1
—
—
—
0
0
5
17
2.94
1.36
1.6
1.1
1.18
1.28
%
—
5
17
205
1766
1.17
1.36
1.3
1.3
—
—
—
0
0
64
486
1.32
1.35
1.3
1.4
—
—
—
0
0
782
8387
0.92
1.34
2.8
4.2
231.36
247.59
u/l
3.18
730
7918
55
730
0.75
1.32
1.8
1.5
60.49
62.66
%
0.17
36
469
41
293
1.40
1.27
2.3
1.8
1.05
2.51
u/field
2.17
22
195
33
472
0.70
1.27
1.1
1.2
0.58
0.63
ratio
0.42
14
107
22
139
1.58
1.22
1.5
1.2
—
—
—
0
0
82
655
1.26
1.21
1.5
1.3
0.21
0.19
nmol/l
0.79
67
535
153
1302
1.18
1.21
4.2
3.7
27.17
30.50
mg/l
0.57
107
934
20
125
1.60
1.17
1.3
1.3
0.34
0.31
g/l
0.39
12
98
101
830
1.22
1.16
9.0
14.7
7.73
7.42
mmol/l
0.20
87
687
211
1848
1.15
1.16
1.5
1.4
265.47
260.02
ug/g
0.15
147
1137
389
4273
0.90
1.15
1.4
1.4
—
—
—
0
0
150
1749
0.85
1.14
1.7
1.4
4.58
16.39
iu/ml
—
5
35
84
679
1.24
1.13
2.0
1.7
239.16
294.48
mu/l
1.87
77
628
100
1207
0.83
1.12
1.2
1.2
425.71
280.64
titre
—
7
94
5
111
0.45
1.12
6.0
7.1
12.30
10.13
%
—
5
111
31
436
0.71
1.11
1.4
1.5
—
—
—
0
0
14
233
0.60
1.11
4.9
4.9
—
58.83
—
0
35
13
73
1.78
1.10
1.0
1.1
—
—
—
0
0
154
1325
1.17
1.09
1.3
1.3
71.57
60.81
mmol/l
2.82
125
1078
127
1494
0.85
1.08
1.3
1.5
0.44
10.52
iu/ml
1.20
38
322
120
1012
1.19
1.08
1.3
1.3
—
—
—
0
0
36
261
1.38
1.07
1.4
1.9
300.79
329.05
mu/l
0.20
28
197
42
558
0.75
1.07
1.3
1.3
—
—
—
0
0
10
52
1.92
1.06
1.1
1.0
—
—
—
0
0
119
1005
1.19
1.06
1.4
1.3
—
—
—
0
0
137
1595
0.86
1.04
1.9
2.3
3.44
3.64
g/l
1.09
128
1519
143
1659
0.86
1.04
1.3
1.5
—
—
—
0
0
53
679
0.78
1.04
1.0
1.1
—
—
—
0
0
144
1668
0.86
1.03
1.3
1.5
0.22
0.31
mg/l
1.28
48
716
20
299
0.67
1.01
1.0
1.1
0.30
0.95
u/ml
—
10
161
75
610
1.23
0.99
1.3
1.3
230986.79
156746.60
e6/l
0.25
56
405
168
1469
1.15
0.98
2.6
2.8
16.07
15.96
%
0.22
168
1439
9
49
1.84
0.98
1.1
1.0
—
—
—
0
0
9
160
0.56
0.97
1.0
1.2
—
—
—
0
0
7
36
1.95
0.97
1.0
1.0
—
—
—
0
0
33
444
0.74
0.94
1.1
1.1
0.93
1.28
u/ml
0.18
19
246
55
690
0.80
0.93
1.0
1.1
1.54
1.57
g/l
0.24
44
623
83
688
1.21
0.93
1.3
1.3
278.54
276.09
mosm/kgh2o
0.41
61
509
31
420
0.74
0.93
1.4
1.5
—
—
—
0
0
22
150
1.47
0.92
1.7
1.6
0.37
0.38
ug/l
0.05
16
91
33
243
1.36
0.92
1.2
1.3
34.45
31.52
u/l
0.21
27
200
21
142
1.48
0.92
1.8
1.5
91.62
477.82
nmol/24h
1.11
21
142
119
1383
0.86
0.91
1.5
1.9
10.75
12.95
mg/l
1.99
108
1269
72
875
0.82
0.91
1.3
1.5
—
—
—
0
0
433
4011
1.09
0.91
2.7
3.7
25.04
24.11
mmol/l
8.80
426
3957
25
349
0.72
0.90
2.0
1.9
—
—
—
0
0
80
664
1.21
0.89
3.3
3.4
13.45
12.18
index
0.32
38
349
39
507
0.77
0.89
2.1
2.2
572.29
653.65
ml
0.66
24
309
27
194
1.39
0.88
2.5
3.0
24.67
29.65
umol/l
1.20
18
144
586
5503
1.07
0.87
2.4
2.5
46.84
39.57
u/l
0.36
485
4631
178
1581
1.13
0.86
1.7
1.6
13632.48
15237.20
e6/l
0.22
130
1088
677
7163
0.94
0.85
5.1
5.5
34.46
33.51
%
1.44
435
4520
46
361
1.28
0.85
1.2
1.3
0.52
1.04
promille
2.37
41
286
20
286
0.70
0.84
1.3
1.3
1.68
429.21
ug/l
—
8
136
2400
23413
1.04
0.83
12.9
13.1
0.00
0.00
e9/l
0.02
1900
18928
70
580
1.21
0.81
1.6
1.7
30.24
26.19
u/ml
0.37
17
119
100
1164
0.86
0.81
1.3
1.2
—
—
—
0
0
163
1833
0.89
0.81
3.3
3.3
0.76
0.83
nmol/l
1.57
127
1466
13
201
0.65
0.81
1.3
1.4
42.00
22.86
%
1.11
13
165
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
15
223
0.67
0.78
1.2
1.2
6.01
6.19
mmol/l
0.34
15
208
27
199
1.36
0.78
1.0
1.1
—
—
—
0
0
91
777
1.17
0.77
1.5
1.3
0.79
0.20
nmol/l
4.45
34
54
241
2644
0.91
0.77
2.7
2.6
—
—
—
0
0
22
303
0.73
0.76
2.3
2.4
40.77
37.46
%
0.46
13
174
73
866
0.84
0.76
1.4
1.5
—
—
—
0
0
150
1683
0.89
0.74
1.3
1.5
—
—
—
0
0
4654
47013
0.96
0.73
22.1
20.8
77.13
71.88
ml/min/173m2
74.28
4401
44091
26
193
1.35
0.73
3.1
6.7
75.00
70.93
%
0.36
17
152
89
1033
0.86
0.72
1.3
1.4
—
—
—
0
0
133
1497
0.89
0.70
1.8
2.1
94.67
88.61
%
2.56
127
1449
25
331
0.75
0.69
1.0
1.1
—
—
—
0
0
26
195
1.33
0.69
1.1
1.3
169.50
167.57
mmol/24h
0.04
26
195
7
120
0.58
0.67
1.1
1.1
—
—
—
0
0
432
4061
1.07
0.67
7.2
9.5
16.27
15.81
%
3.12
414
3929
5
92
0.54
0.67
23.6
13.7
4.28
5.01
mmol/l
—
5
92
16
226
0.71
0.66
1.0
1.3
—
—
—
0
0
28
362
0.77
0.66
1.0
1.0
1.14
2.57
u/ml
1.38
13
171
26
339
0.77
0.65
1.0
1.1
—
—
—
0
0
26
339
0.77
0.65
1.0
1.1
—
—
—
0
0
125
1404
0.89
0.65
2.3
2.4
192.03
211.98
%
2.02
117
1339
108
952
1.14
0.64
5.4
6.2
12.52
12.42
mg/l
0.07
95
884
154
1388
1.11
0.63
4.3
4.6
2.48
2.64
mmol/l
0.32
118
953
154
1389
1.11
0.63
4.3
4.6
5.10
5.00
kpa
0.97
148
1362
45
546
0.82
0.63
1.1
1.3
1.51
1.52
g/l
0.12
45
546
47
567
0.83
0.62
1.7
1.5
24.08
27.25
%
0.25
29
357
87
758
1.15
0.61
1.4
1.3
0.64
3.01
nmol/l
0.51
82
725
25
324
0.77
0.61
1.0
1.1
—
—
—
0
0
194
1774
1.10
0.61
1.4
1.5
—
—
—
0
0
62
728
0.85
0.61
2.8
3.6
57.04
58.49
%
0.17
49
609
10
151
0.66
0.59
1.3
1.1
—
—
—
0
0
31
245
1.27
0.59
1.3
1.3
—
—
—
0
0
66
567
1.17
0.57
1.7
1.4
30.89
31.12
iu/l
0.02
55
480
142
1285
1.11
0.56
1.6
1.5
—
—
—
0
0
90
793
1.14
0.56
1.3
1.4
—
—
—
0
0
8
55
1.46
0.56
1.1
1.3
1.33
1.84
umol/24h
—
8
55
49
581
0.84
0.55
1.4
1.5
—
—
—
0
0
25
194
1.29
0.55
1.4
1.3
61.44
60.08
%
0.05
17
164
52
613
0.85
0.55
1.6
1.4
12.69
13.08
u/l
0.17
52
588
4673
47115
0.97
0.55
7.1
7.6
39.78
40.63
mmol/mol
9.64
4261
43142
184
1690
1.09
0.55
1.6
1.6
35.53
27.56
u/ml
0.35
27
258
1656
16959
0.97
0.55
2.9
3.3
31.67
36.80
u/l
1.85
1549
15852
8
122
0.66
0.54
1.3
1.5
—
—
—
0
0
78
683
1.14
0.54
1.3
1.6
58.26
28.73
ng/l
0.86
78
683
19
250
0.76
0.53
1.2
1.4
31.55
20.83
umol/l
0.67
19
230
16
216
0.74
0.53
1.3
1.5
6.85
14.28
umol/l
—
10
140
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
11
74
1.49
0.53
1.3
1.3
65.40
77.23
%
—
5
26
128
1158
1.11
0.52
1.4
1.8
47.93
45.36
nmol/l
0.72
123
1105
386
3653
1.06
0.52
1.5
1.7
1.57
1.56
g/l
0.05
330
3155
16
215
0.74
0.52
1.1
1.1
—
—
—
0
0
85
751
1.13
0.52
1.3
1.4
—
—
—
0
0
29
358
0.81
0.50
1.0
1.1
—
—
—
0
0
85
753
1.13
0.50
1.3
1.4
—
—
—
0
0
88
782
1.13
0.50
1.3
1.4
—
—
—
0
0
16
118
1.36
0.50
1.3
1.4
66.09
80.69
%
0.95
11
67
54
627
0.86
0.49
1.2
1.2
2.33
3.71
u/ml
0.84
21
203
128
1163
1.10
0.49
1.5
1.8
3.76
9.36
iu/l
0.48
43
403
65
567
1.15
0.48
1.1
1.1
55.55
19.67
au/ml
—
6
74
7
108
0.65
0.48
2.3
2.9
90.71
1278.14
u/l
—
7
102
17
223
0.76
0.48
1.8
2.5
0.60
0.62
mmol/l
0.39
17
223
85
756
1.13
0.48
1.3
1.4
—
—
—
0
0
41
485
0.84
0.47
1.1
1.1
—
79.38
—
0
13
45
528
0.85
0.47
1.1
1.6
—
—
—
0
0
45
528
0.85
0.47
1.1
1.6
—
—
—
0
0
45
528
0.85
0.47
1.1
1.6
—
—
—
0
0
17
222
0.77
0.47
3.3
4.1
13.62
13.40
%
0.35
17
222
87
777
1.12
0.46
1.3
1.4
—
—
—
0
0
119
1082
1.10
0.46
2.2
1.9
1.65
1.71
mmol/l
0.16
119
1055
5127
50969
1.03
0.46
11.8
13.7
18.99
25.13
u/l
126.18
4848
49103
89
797
1.12
0.46
1.4
1.4
10.39
10.69
u/l
0.10
70
637
82
731
1.12
0.45
1.2
1.3
230.41
278.75
pmol/l
1.19
64
604
8
119
0.67
0.45
1.0
1.2
—
—
—
0
0
133
1451
0.91
0.45
1.3
1.5
0.22
0.24
g/l
1.50
120
1382
14
103
1.36
0.45
1.2
1.2
—
—
—
0
0
26
210
1.24
0.45
1.2
1.4
142.42
90.51
umol/l
0.24
12
126
248
2636
0.94
0.44
1.3
1.3
366.07
255.15
u/ml
0.32
227
2414
182
1954
0.93
0.43
1.3
1.6
9.17
6.38
iu/ml
0.63
47
463
8
56
1.43
0.42
4.9
2.5
0.75
0.37
u/field
—
8
56
17
131
1.30
0.42
1.1
1.2
—
—
—
0
0
79
880
0.90
0.41
1.2
1.1
—
0.93
—
0
16
39
332
1.18
0.41
1.3
1.4
—
—
—
0
0
39
332
1.18
0.41
1.3
1.4
—
—
—
0
0
23
283
0.81
0.41
1.1
3.7
84.50
66.75
mg/l
—
10
197
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
8.28
—
0
16
142
1535
0.92
0.41
2.1
2.3
119.50
94.31
ug/min
0.36
78
866
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
11.35
—
0
11
26
213
1.22
0.40
2.2
2.4
5.19
4.91
kpa
0.29
26
213
34
401
0.85
0.40
1.1
1.2
—
—
—
0
0
101
920
1.10
0.40
1.6
1.9
193.07
197.41
pmol/l
0.16
96
851
65
730
0.89
0.40
3.8
3.6
—
—
—
0
0
26
314
0.83
0.39
1.6
1.4
0.69
1.84
u/ml
0.73
19
186
34
400
0.85
0.39
1.3
1.2
66.67
121.72
titre
—
9
64
26
214
1.22
0.39
2.2
2.4
9.53
10.01
kpa
0.58
26
214
644
6656
0.96
0.39
2.2
2.7
8.73
9.87
umol/l
0.59
574
5865
76
844
0.90
0.39
1.4
1.3
—
—
—
0
0
12
89
1.35
0.37
1.5
1.4
59.14
70.50
%
0.48
12
73
227
2401
0.94
0.37
1.2
1.2
96.47
121.27
u/ml
0.45
84
809
15
116
1.29
0.37
1.4
1.2
0.55
0.71
umol/24h
—
8
55
94
1028
0.91
0.36
1.3
1.4
0.81
0.83
nmol/l
0.13
76
852
37
428
0.86
0.36
1.4
1.8
85.66
118.10
ng/l
2.23
37
428
26
309
0.84
0.35
2.3
3.4
1.15
1.24
%
0.13
26
309
58
518
1.12
0.34
1.1
1.2
—
—
—
0
0
10
73
1.37
0.34
1.1
1.4
79.40
76.46
%
—
5
28
40
350
1.14
0.32
1.4
1.2
22.55
26.82
u/l
0.26
33
285
140
1493
0.94
0.31
1.3
1.5
1.14
1.17
g/l
0.71
128
1420
27
231
1.17
0.29
1.4
1.4
151.90
189.48
pmol/l
0.41
27
231
12
152
0.79
0.29
2.4
2.4
5.25
277.33
ug/l
0.81
12
152
34
299
1.14
0.27
1.7
1.7
39.41
39.38
g/l
0.01
34
299
54
594
0.91
0.26
1.1
1.6
—
—
—
0
0
55
500
1.10
0.26
1.3
1.4
251.25
231.25
titre
—
8
48
212
2216
0.96
0.26
1.4
1.7
36.28
38.57
u/l
1.02
181
1890
5
75
0.67
0.25
3.0
1.6
23.20
45.08
umol/l
—
5
75
56
613
0.91
0.25
1.2
1.2
2.19
5.30
u/ml
2.81
26
284
38
424
0.90
0.24
1.2
1.1
5.00
2.24
eliau/ml
—
8
107
52
570
0.91
0.24
1.1
1.1
—
—
—
0
0
102
1086
0.94
0.24
1.4
1.7
4.44
4.83
mg/l
0.13
82
838
67
725
0.92
0.24
3.7
3.5
3.96
23.26
nmol/l
1.13
62
709
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
43
475
0.90
0.24
1.3
1.4
—
—
—
0
0
205
1966
1.04
0.23
1.1
1.1
—
—
—
0
0
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
17
143
1.19
0.23
1.2
1.5
0.17
0.30
mmol/l
—
6
28
40
361
1.11
0.22
1.4
1.2
93.18
94.78
u/l
0.03
33
300
905
8891
1.02
0.22
1.4
1.5
2.39
2.72
g/l
2.62
443
5057
14
168
0.83
0.22
1.1
1.7
2.01
1.86
umol/l
0.29
14
151
7
91
0.77
0.22
1.0
1.2
—
—
—
0
0
7
92
0.76
0.22
1.0
1.3
—
5216.36
—
0
11
421
4100
1.03
0.21
1.5
1.7
1.47
1.61
%
4.68
355
3385
26
229
1.14
0.21
1.1
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
110.17
—
0
6
187
1795
1.04
0.21
1.1
1.2
1.28
1.09
u/ml
0.06
20
162
5
43
1.16
0.21
1.4
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
12.37
—
0
6
447
4363
1.03
0.20
5.6
7.5
25.21
24.76
mmol/l
1.62
441
4335
0
14
0.00
0.20
0.0
6.2
—
387.14
—
0
14
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
21
183
1.15
0.20
1.1
1.1
2305.90
1520.87
miu/ml
1.66
21
183
14
165
0.85
0.19
1.4
1.3
—
—
—
0
0
35
385
0.91
0.19
2.7
3.9
—
—
—
0
0
39
356
1.10
0.19
4.4
5.4
74.18
56.02
u/ml
—
9
109
42
456
0.92
0.18
2.7
1.9
8.56
8.14
mmol/l
0.27
42
456
621
6098
1.02
0.18
2.0
2.2
0.20
0.20
g/l
0.02
567
5647
13
110
1.18
0.17
1.0
1.3
—
—
—
0
0
439
4481
0.98
0.16
2.1
2.2
12.78
12.38
nmol/l
0.47
384
3878
17
193
0.88
0.15
1.1
1.3
6.06
12.65
pmol/l
—
6
79
6
76
0.79
0.15
1.3
1.3
14.70
6.42
nmol/l
—
6
62
6
77
0.78
0.15
2.7
3.8
29.77
40.43
umol/l
—
6
66
6
78
0.77
0.15
1.2
1.1
—
—
—
0
0
20
178
1.12
0.15
1.1
1.2
—
—
—
0
0
9
81
1.11
0.15
1.0
1.1
—
—
—
0
0
12
139
0.86
0.14
1.3
1.4
1.18
1.17
mmol/l
0.15
12
139
29
315
0.92
0.13
1.7
1.3
1.06
1.13
nmol/l
0.15
22
225
66
627
1.05
0.13
1.3
1.2
67.83
66.06
u/l
0.08
57
542
138
1426
0.97
0.13
1.7
2.4
59.31
60.51
%
0.27
138
1420
27
294
0.92
0.13
3.7
3.2
220.37
208.54
u/l
0.28
27
288
12
138
0.87
0.13
1.3
2.2
150.33
204.95
%
2.37
12
131
85
815
1.04
0.12
2.3
1.8
89.08
89.06
%
0.01
85
804
437
4300
1.02
0.12
6.5
8.7
24.78
24.21
mmol/l
3.30
425
4184
27
249
1.08
0.11
5.9
6.6
5.46
210.74
ug/l
0.95
15
157
36
384
0.94
0.11
1.8
1.8
—
—
—
0
0
1414
14244
0.99
0.11
3.4
3.6
0.75
0.83
ug/l
2.79
1034
10404
119
1228
0.97
0.11
1.2
1.4
—
—
—
0
0
80
772
1.04
0.09
1.9
3.0
8.92
10.79
mmol/l
5.39
80
762
69
664
1.04
0.09
2.6
3.3
—
—
—
0
0
16
176
0.91
0.09
1.1
1.4
—
1536824.88
—
0
8
52
543
0.96
0.09
1.4
1.4
—
—
—
0
0
6
55
1.09
0.08
1.0
1.0
—
—
—
0
0
6
57
1.05
0.08
3.2
4.2
—
—
—
0
0
68
704
0.97
0.08
1.1
1.1
31.29
587.20
iu/ml
0.84
14
133
119
1219
0.98
0.08
1.3
1.4
—
—
—
0
0
34
358
0.95
0.08
1.7
1.5
4.74
7.24
u/l
1.03
27
279
23
215
1.07
0.07
1.1
1.2
—
—
—
0
0
886
8802
1.01
0.07
4.2
5.9
1.00
1.04
mmol/l
4.21
805
8154
9
85
1.06
0.07
1.0
1.0
—
—
—
0
0
9
88
1.02
0.07
1.1
1.1
—
—
—
0
0
11
99
1.11
0.06
1.0
1.3
—
—
—
0
0
70
719
0.97
0.06
1.4
1.4
—
—
—
0
0
64
625
1.02
0.04
1.1
1.6
—
—
—
0
0
276
2736
1.01
0.04
2.1
3.3
39.94
55.34
mg/l
1.14
231
2328
17
180
0.94
0.04
1.1
1.1
—
—
—
0
0
171
1729
0.99
0.04
1.5
1.4
—
—
—
0
0
119
1176
1.01
0.03
1.6
1.5
—
—
—
0
0
36
370
0.97
0.03
1.3
1.4
—
—
—
0
0
36
370
0.97
0.03
1.3
1.4
—
—
—
0
0
46
450
1.02
0.02
3.1
2.8
24.21
32.68
mg/l
0.93
33
348
4791
47886
1.00
0.02
5.6
6.0
6.01
6.13
mmol/l
10.85
4266
42881
142
1409
1.01
0.02
1.7
1.6
—
—
—
0
0
469
4678
1.00
0.01
3.0
2.8
66.98
59.63
ml/min/173m2
3.14
182
2085
56
553
1.01
0.01
1.1
1.2
117.49
112.84
%
0.42
51
488
247
2462
1.00
0.01
2.0
3.2
2.58
5.06
ratio
0.95
149
1457
12
126
0.95
0.00
4.3
6.5
8.71
8.67
mmol/l
0.01
12
126
14
146
0.96
0.00
2.9
2.3
7.83
7.53
mmol/l
—
8
90
15
156
0.96
0.00
1.4
1.3
50.70
36.49
%
—
10
105
30
294
1.02
0.00
1.2
1.2
—
—
—
0
0
93
924
1.01
0.00
1.7
1.8
4.46
4.46
mmol/24h
0.01
81
783
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
18
185
0.97
0.00
1.4
2.1
134.17
180.89
%
2.19
18
174
12
123
0.98
0.00
1.2
1.5
16.17
13.50
mm/h
0.17
12
123
30
296
1.01
0.00
1.2
1.2
—
—
—
0
0
25
247
1.01
0.00
1.1
1.1
—
—
—
0
0
141
1407
1.00
0.00
1.3
1.4
—
—
—
0
0
33
331
1.00
0.00
2.1
1.7
84.36
93.22
umol/l
0.81
33
331
58
579
1.00
0.00
2.0
2.3
550.14
955.50
mg
1.76
58
573
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
7
77
0.91
0.00
3.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
52
0.96
-0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
0.01
—
0
9
274
2740
1.00
-0.00
2.1
3.3
46.59
80.45
mg/l
1.02
230
2334
6
68
0.88
-0.00
1.2
1.7
—
0.41
—
0
13
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
60
1.00
-0.00
1.3
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
13.10
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR – Use of levodopa decarboxylase inhibitor
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).